Back to Search
THOMAS EISEN, MD
MD
Nephrology Physician
NPI: 1427044684IndividualAccepts Medicare
Specialties, Licenses & Credentials
Nephrology PhysicianPrimary
Internal Medicine — Nephrology
Code: 207RN0300X
28182(CT)
Education
NEW YORK UNIVERSITY MEDICAL COLLEGE - NLG
Class of 1983
Research & Publications (20)
Identification of low penetrance alleles for lung cancer: the GEnetic Lung CAncer Predisposition Study (GELCAPS).
PMID 18715499·BMC Cancer·2008
8-other
Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer.
PMID 18786981·Thorax·2009
4-observational
Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer.
PMID 19221182·Br J Radiol·2009
4-observational
Cytoreductive nephrectomy in metastatic clear-cell renal cell carcinoma: perspectives in the tyrosine kinase inhibitor era.
PMID 19147692·Oncologist·2009
6-review
Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma.
PMID 19436178·Melanoma Res·2009
3-trial
Structural bioinformatics mutation analysis reveals genotype-phenotype correlations in von Hippel-Lindau disease and suggests molecular mechanisms of tumorigenesis.
PMID 19408298·Proteins·2009
8-other
Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.
PMID 19117638·Lung Cancer·2009
8-other
Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study.
PMID 19654303·Cancer Res·2009
1-meta
UK guidelines for the systemic treatment of renal cell carcinoma.
PMID 19451873·Br J Hosp Med (Lond)·2009
6-review
Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.
PMID 19451442·J Clin Oncol·2009
3-trial
Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer.
PMID 18692272·Lung Cancer·2009
3-trial
Immunotherapeutic strategies in kidney cancer--when TKIs are not enough.
PMID 19546865·Nat Rev Clin Oncol·2009
6-review
Sorafenib for older patients with renal cell carcinoma: subset analysis from a randomized trial.
PMID 18840822·J Natl Cancer Inst·2008
2-rct
Multiple combined sclerosing haemangiomas and tumourlets. A report of two patients with bilateral disease.
PMID 18983474·Histopathology·2008
5-case
Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.
PMID 18385676·Nat Genet·2008
8-other
Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer.
PMID 18780872·J Natl Cancer Inst·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 136 SHERMAN AVE, 405
NEW HAVEN, CT 06511 - Phone
- (203) 787-0117
Quick Facts
- NPI
- 1427044684
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 43
- Publications
- 20
Are you this provider?
Claim Your Profile